On April 26, 2018, the State Drug Administration issued for public comment the Implementing Measures for the Protection of Drug Trial Data (for Interim Implementation) (Draft for Comment) (the “Implementing Measures”) . Compared with the previous Relevant Policies on Encouraging Innovation in Drug and Medical Equipment and Protecting the Rights and Interests of Innovators (Draft for Comment) (“Relevant Policies”) , and Opinions on Deepening the Reform of the Evaluation and Approval System and Encouraging Innovations in Drugs and Medical Devices , the Implementing Measures unprecedentedly expand the duration and scope of data protection for specialized drugs and, for the first time, implement data protection application, review, public notice of authorization, objection and revocation mechanisms.